SOURCE: Dynavax Technologies

Dynavax Technologies

July 02, 2013 09:00 ET

Dynavax to Present at the JMP Securities Healthcare Conference

BERKELEY, CA--(Marketwired - Jul 2, 2013) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it will present at the JMP Securities Healthcare Conference in New York on Wednesday, July 10 at 9:00 a.m. EDT (6:00 a.m. PDT).

Michael Ostrach, Chief Business Officer of Dynavax, will provide a corporate overview presentation. To access the slide presentation, live webcast, and subsequent archived recording, please visit Dynavax's website at

About Dynavax

Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. Dynavax's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine. For more information visit

Contact Information

  • Contact:
    Michael Ostrach
    Vice President and Chief Business Officer
    Email Contact